These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 2714226)

  • 1. Tritiation of [8-L-arginine, 9-desglycineamide] vasopressin.
    Hrbas P; Cerný B; Papsuevich OS; Chipens GI; Ermisch A; Barth T
    Endocrinol Exp; 1989 Mar; 23(1):37-42. PubMed ID: 2714226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tritiation of vasopressin analogues and their metabolic fate after intravenous injection in the rat.
    Janáky T; László FA; Morgat JL
    Acta Med Hung; 1984; 41(1):43-54. PubMed ID: 6739223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tritium-labeled reactive analogs of [1,6-alpha-aminosuberic acid, 8-arginine] vasopressin (deamino-dicarba-[8-arginine] vasopressin. synthesis and properties].
    Fahrenholz F; Husseini HS; Morgat JL; Thierauch KH
    Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1415-26. PubMed ID: 7160823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of tritiated alpha-melanotropin with high specific radioactivity.
    Buckley DI; Ramachandran J
    Int J Pept Protein Res; 1981 Apr; 17(4):514-8. PubMed ID: 7309356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological half-life and organ distribution of [3H]8-arginine vasopressin following administration of vasopressin receptor antagonist OPC-31260.
    Molnár AH; Varga C; Janáky T; Tóth G; Tóth G; Farkas J; László F; László FA
    Regul Pept; 2007 Jun; 141(1-3):12-8. PubMed ID: 17258819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 8-D-arginine vasopressin analogues, modified in position 1 as antagonists of the vasopressor response to the parent hormone.
    Lammek B; Derdowska I; Melin P
    Pol J Pharmacol Pharm; 1988; 40(4):423-8. PubMed ID: 3222181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of vasopressin analogues by reversed-phase high-performance liquid chromatography.
    Lindeberg G
    J Chromatogr; 1980 May; 193(3):427-31. PubMed ID: 7380967
    [No Abstract]   [Full Text] [Related]  

  • 9. Constrained refinement based on NOE and chemical shift information: the monomer form of arginine-vasopressin-like insect factor.
    Busetta B; Picard P
    J Pept Sci; 1997; 3(2):133-40. PubMed ID: 9230478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonist.
    Kowalczyk W; Sobolewski D; Prahl A; Derdowska I; Borovicková L; Slaninová J; Lammek B
    J Med Chem; 2007 Jun; 50(12):2926-9. PubMed ID: 17500550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodination of vasopressin analogues with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors.
    Jard S; Lombard C; Seyer R; Aumelas A; Manning M; Sawyer WH
    Mol Pharmacol; 1987 Sep; 32(3):369-75. PubMed ID: 2959851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activities of some new arginine vasopressin analogues containing unusual amino acids.
    Varga C; Somlai C; Baláspiri L; László FA
    Acta Physiol Hung; 1993; 81(2):183-92. PubMed ID: 8197874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells.
    van Bree JB; de Boer AG; Verhoef JC; Danhof M; Breimer DD
    J Pharmacol Exp Ther; 1989 Jun; 249(3):901-5. PubMed ID: 2732952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide synthesis using novel S-sulfocysteine derivatives.
    Maugras I; Gosteli J; Rapp E; Nyfeler R
    Int J Pept Protein Res; 1995 Feb; 45(2):152-6. PubMed ID: 7782163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical investigation of nocturnal polyuria in patients with nocturia: a diurnal variation in arginine vasopressin secretion and its relevance to mean blood pressure.
    Natsume O
    J Urol; 2006 Aug; 176(2):660-4. PubMed ID: 16813917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatography method with radiochemical detection for measurement of nitric oxide synthase, arginase, and arginine decarboxylase activities.
    Volke A; Wegener G; Vasar E; Volke V
    Methods Find Exp Clin Pharmacol; 2006; 28(1):3-6. PubMed ID: 16541190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro evidence of blood-brain barrier transport of a novel cationic arginine-vasopressin fragment 4-9 analog.
    Tanabe S; Shimohigashi Y; Nakayama Y; Makino T; Fujita T; Nose T; Tsujimoto G; Yokokura T; Naito M; Tsuruo T; Terasaki T
    J Pharmacol Exp Ther; 1999 Aug; 290(2):561-8. PubMed ID: 10411563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
    Czakó L; László F; Manning M
    Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
    [No Abstract]   [Full Text] [Related]  

  • 20. A DNA aptamer as a new target-specific chiral selector for HPLC.
    Michaud M; Jourdan E; Villet A; Ravel A; Grosset C; Peyrin E
    J Am Chem Soc; 2003 Jul; 125(28):8672-9. PubMed ID: 12848575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.